Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. - Test2 - elhamkhani - TriplyDB

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

http://www.wikidata.org/entity/Q37648626

about

Metagenomics: The Next Culture-Independent Game Changer.Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.The global epidemiology of carbapenemase-producing Enterobacteriaceae.Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.Culture-independent analysis of liver abscess using nanopore sequencing.Complete genome sequence of Enterobacter cloacae R11 reveals multiple genes potentially associated with high-level polymyxin E resistance.Charged Metallopolymer-Grafted Silica Nanoparticles for Antimicrobial Applications.Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report.The Infinity War: How to Cope with Carbapenem-resistant Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran

P2860

Q33867106-A281E164-168A-4755-952C-DDF46D34E3FE Q37563608-1B858187-8FED-4009-8F59-8EECA36B8193 Q39157514-FF824425-DA1C-4D83-9354-0B1EAEE895BC Q40552344-43C1DFA6-7BCC-436F-B9F4-E22A87E05D02 Q47105309-84A71D5C-9B4A-4173-8F3F-A7772267CC58 Q47190121-791CF3E0-2AD6-40DE-9651-C8DA2FFBAC24 Q47407553-6982212C-56B1-4EB3-8192-5F4EAA5668F1 Q48134551-D4B15A55-0E09-47B6-8C0A-503E229E341E Q55250799-C0612DDB-D865-4F88-B399-B03958D79E2F Q55425202-0948C5F6-BD1B-47F2-982A-CD961F830A47 Q57118424-77C2FE35-EF6C-425A-B5AA-245601743800 Q58802622-0619D885-9361-40CC-8B30-141DA614ADC2 Q59127513-F94623B7-78CA-4F01-B02E-D4D97C0E36B7

P2860

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

http://www.wikidata.org/entity/Q37648626

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@en

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@nl

type

label

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@en

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@nl

prefLabel

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@en

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@nl

P1433

Q37648626-187D2E8C-E613-4105-B701-F14FB08B5980

P1476

Q37648626-03BB15AB-FB54-4A2C-BDE2-EAF29F65A7F2

P2093

Q37648626-32C12A5B-A450-4383-93DF-CBA02F237CE4

P2860

Q37648626-0061C782-B820-40A2-8007-33049EBB72E8

Q37648626-04AE9E7E-EE93-471E-8D86-0E9E5260387F

Q37648626-07CB721A-9E93-462E-87DA-0B4C63650702

Q37648626-0B8BCD75-0A9B-4CD6-9962-674194D84A46

Q37648626-103F335B-3377-4A17-B107-AD77D4F0B626

Q37648626-14CAA126-24B9-4067-A57C-A38E184FA245

Q37648626-1692EFE3-D5BD-468C-8015-30A0FD630571

Q37648626-1C3B45AB-8633-472E-B4A2-37C15A0922FA

Q37648626-25AAD51F-16B9-4489-AB70-5A1CDEEC3D31

Q37648626-260903DC-9221-41D5-BF0E-2C858C40B156

P304

Q37648626-59566286-A020-4862-8CCD-0473D59EE905

P31

Q37648626-3467BD93-C29B-4098-B57F-822665876245

Q37648626-cc52d757-048a-4116-bcc9-512724961c54

P356

Q37648626-237B0F34-36B7-4A54-8A4A-963D6ABEB7B3

P433

Q37648626-A21F4282-7707-4935-997C-3A9DC966DEC0

P478

Q37648626-DE63666D-D9CB-4BA9-8744-CCCCBFC3ADD6

P50

Q37648626-05033FE5-D645-4BCF-86E9-928F3E56329F

P577

Q37648626-1C74EBA7-7D5C-492C-9D74-AF6B2D60245E

P698

Q37648626-B8E78C9B-2664-465C-8244-018761059202

P921

Q37648626-928FC3B7-9021-4F7C-B996-6EF68CFA3F41

P932

Q37648626-2A8BD8A9-55F9-4AE6-BC6B-4A63606CE7BA

P356

J.IDC.2016.02.004

P1433

Infectious Disease Clinics of North America

P1476

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

@en

P2093

David van Duin

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Infection Control in Cystic Fibrosis: Cohorting, Cross-Contamination, and the Respiratory Therapist

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

Combating antimicrobial resistance: policy recommendations to save lives

Bacterial biofilms: a common cause of persistent infections

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria

Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci

P304

377-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IDC.2016.02.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

David L Paterson

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27208764

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5314345

http://www.w3.org/2001/XMLSchema#string